Foglietta, M <br/><br/>
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2013 
 - 269-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Epitopes<br/>Female<br/>HLA Antigens--immunology<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Hemocyanins--administration & dosage<br/>Humans<br/>Immunity, Cellular--immunology<br/>Immunization--methods<br/>Immunoglobulin Idiotypes--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Tissue Donors<br/>Transplantation Immunology<br/>Transplantation, Homologous